in alphabetical order
Professor for Systems Biology, Weizmann Institute of Science, Israel
Professor Dr. Erwin Böttinger is Professor and Chair of Digital Health and Personalized Medicine at the joint Digital Engineering Faculty of the Hasso Plattner Institute (HPI) gGmbH and the University of Potsdam. He is the founding director of the HPI Digital Health Center. From November 2015 to July 2017 Prof. Böttinger was Chairman of the Board of the Berliner Instituts für Gesundheitsforschung/Berlin Institute of Health (BIH). Prof. Böttinger is considered an international expert in personalized medicine and digital health, in particular from his services as founding director of the Charles Bronfman Institute for Personalized Medicine at the Icahn School of Medicine at Mount Sinai in New York, USA, from 2005 to 2015.
Stefan Günther is currently the head of the next-generation core facility, Bioinformatics and Deep Sequencing Platform at the Max-Planck-Institute for Heart- and Lung Research in Bad Nauheim. He studied biology at the Martin-Luther University Halle-Wittenberg, where he received his Diploma in 2002. For is PhD, he joined the MPI for Heart-and Lung research. There he investigated muscle-specific transcription factors. From 2009 - 2013 he was a postdoctoral research fellow at the department of cardiac development and remodeling with Prof. Dr. Thomas Braun with focus on muscle stem cells. Dr. Günther is co-author of numerous publications in the area of nucleic acid research and single-cell sequencing.
Peter Jansen is currently the program director of LiSyM, the Liver Systems Medicine research network in Germany. Peter Jansen is honorary professor at MaCSBio, the Maastricht Center for Systems Biology and he is emeritus professor of hepatology at the Universities of Amsterdam and Groningen.
He studied Medicine at the University of Nijmegen and received his PhD at the Institute of Pharmacology with work on drug metabolism in 1975. For part of his scientific training he went to the Albert Einstein College of Medicine in New York (1973-76). In 1986 he became associate professor at the AMC in Amsterdam and in 1993 he was appointed professor of hepatology and head of the department of Gastroenterology and Hepatology in the University Medical Center in Groningen, the main liver transplantation center in the Netherlands. In 2003 he returned to Amsterdam as head of the liver unit. Peter’s research is devoted to trans-membrane ABC transport proteins, interaction between liver and intestine, FGF19-signalling, nuclear hormone receptors and the role of bile salts in cholestatic and metabolic liver disease.
Research in the group of Oliver Kohlbacher (Chair for Applied Bioinformatics) focuses on method development for the analysis of high-throughput data, immunoinformatics, and structural bioinformatics. A particular focus is on the analysis of mass spectrometric data (proteomics, metaproteomics, metabolomics), for which is group has been developing open-source software (OpenMS) for a long time. Integrating these approaches, automating analyses and bringing the resulting workflows to the clinical application has been another focus of recent years. Oliver Kohlbacher is also the director of the Quantitative Biology Center (QBiC) and a fellow of the Max Planck Institute for Developmental Biology in Tübingen.
Conor Liston is an Assistant Professor of Neuroscience and Psychiatry at the Feil Family Brand and Mine Research Institute and Department of Psychiatry at Weill Cornell Medicine. He studied Medicine and Neuroscience at Harvard and Weill Cornell Medical College and received his PhD from the Rockefeller University. After postdoctoral research at New York University and at Stanford, he became an Assistant Professor of Neuroscience at Weill Cornell in 2014. His research seeks to identify prefrontal circuit mechanisms supporting learning and memory and to understand how they are disrupted in stress-related psychiatric disorders, operating at the interface between systems neuroscience and biological psychiatry.
Dr. Markus Löffler is Professor and Director of the Institute of Medical Informatics, Statistics and Epidemiology in Leipzig. He is the acting director of the Center of Clinical Trials Leipzig, scientific director of the Interdisciplinary Center for Bioinformatics, as well as the director of the LIFE Research Center for Civilisation Diseases.
He is originally trained as a physicist and medical doctor and was promoted as a professor in medical documentation, statistics and biomathematics from the University of Cologne. In 1994 he became a full Professor and head of the Institute at the University of Leipzig. His research interests include clinical trials and cohort studies for molecular markers, bioinformatics, systems biology models as well as medical statistics and epidemiology. Dr. Löffler has an h-index of 87 and published numerous publications with far more than 30.000 citations.
Jan-Philipp Mallm performed his PhD work in the group of Karsten Rippe at the German Cancer Research Center (DKFZ, Heidelberg). Here he studied chromatin feedback on telomere maintenance in embryonic stem cells and on DNA repair in cancer initiating cells.
During his postdoc he exploited epigenetic deregulation in chronic lymphocytic leukemia (CLL) revealing a transcription factor network controlling the disease phenotype. Since 2015 he heads the Chromatin and RNA methods (CHARM) lab within the Heidelberg Center for Personalized Oncology (HIPO) establishing (single-cell) sequencing readouts for primary tumor samples.
In addition, in 2017 he started as a Team Leader for dissecting cellular heterogeneity in leukemic patients by single-cell sequencing approaches in the division of Karsten Rippe.
Head of the Department of Preclinical Imaging and Radiopharmacy, University of Tuebingen
Professor, Center for Biotechnology - CeBiTec, University of Bielefeld
Coordinator, German network for Bioinformatics Infrastructure (de.NBI)
- Fully Qualified Lawyer studies in Augsburg
- Master of Laws degree in Information Technology Law from Oldenburg University
- Previously consultant at several community law centers in Germany and New Zealand
- Since 2011 Attorney at Law specialising in data protection law and External Data Protection Officer for numerous companies in various industry sectors at Scheja & Partner Attorneys at Law, Bonn, Germany
- Since 2014 Research Assistant at Oldenburg University, specialising in data protection and IT law
- Regular speaker at national and international data protection conferences
- Certified Data Protection Officer
Director, Institute for Clinical Molecular Biology (IKMB), Kiel University
After his studies in Marburg and Manchester, Andreas Schlitzer did his PhD at the Technical University of Munich with a focus on dendritic cells. After his PhD he moved to the lab of Florent Ginhoux, Singapore Immunology Network, Singapore were he investigated how the functional polarization of myeloid cells is enforced using various single cell biology approaches, such as single cell transcriptomics, high dimensional flow cytometry and mass cytometry. Since 2016 he is an Emmy Noether Group leader at the Life & Medical Sciences Institute of the University of Bonn and employs an integrated single cell biology approach to identify the molecular mechanisms guarding myeloid cell differentiation and functional polarization during inflammation.
Dr. Schwikowski is a pioneer in the area of computational network and systems biology, and applications to biomedical problems. After training as a mathematician and computer scientist in Germany and the U.S., Dr. Schwikowski joined the Institute for Systems Biology in Seattle as one of its first group leaders. Besides creating algorithms around transcriptomics and proteomics, he established the ‘guilt by association’ principle to integrate molecular interaction data with protein function and transcriptomic data. His Cytoscape platform for the data-driven analysis of biological networks, is today one of the most widely used bioinformatics tools. Now at the Pasteur Institute in Paris, Dr. Schwikowski’s group focuses on methods that enable data-driven strategies for disease stratification and biomarker discovery in immune-related and other complex diseases.
Julia C Stingl (formerly Kirchheiner) M.D. is professor of translational pharmacology at the University Bonn Medical Faculty and head of the research division of the Federal Institute of Drugs and Medical Devices. Since 2014 she is Vice President of the institute.
Her research focuses on individualized drug treatment optimized by pharmacogenetics. She developed dose adjustments based on differences in drug clearances caused by pharmacogenetic polymorphisms promoting the way of pharmacogenetics from bench to bedside. She explored genetic influences on drug response and worked on characterization of the physiological role of genetic polymorphisms. She integrated new pharmacogenetic methods such as brain imaging techniques for visualization of pharmacogenetics modulation of individual drug effects. She has more than 190 peer-reviewed scientific publications, has been cited more than 6200 times with an average citation of 25 per article and an H-index of 43 (ISI web of science, August 2017).
Dr. Angela Vasaturo is a Senior Researcher in the field of Tumor Immunology in the Integrative Cancer Immunology at the Cordeliers Research Center in Paris, France.
Dr. Vasaturo was trained as a Medical Biotechnologist and pursued a Ph.D. degree in Chemical Engineering (both at University of Naples “Federico II”, Naples, Italy). She’s been working as Post-doctoral researcher at the NCMLS in the years 2010-2015, being the recipient of an EMBO short-term fellowship, amongst others. She joined Dr. Jerome Galon’s Laboratory of Integrative Cancer Immunology at the Cordeliers Research Center in 2015.
Dr Vasaturo has a sound knowledge on a broad range of in vivo and in vitro skills, and has a keen interest in microscopy and state-of-the-art imaging techniques, including Multispectral Imaging.
Dr. Vasaturo has published 16 papers in top-tier scientific journals, delivered seminars and tutorials internationally and carried out multiple collaborations in the field.
Antje Walz, Senior Principal Scientist, Translational Modelling & Simulation, Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland.
Antje received her PhD in Biology from the University Konstanz, Germany in 2002. She brings 15 years of experience in drug discovery and development of small and large molecules. Since 2008, she works in the translational Modelling and Simulation group at Roche. Her main interest is to predict efficacy, biomarker and safety profiles in cancer patients based on nonclinical information. In her role as Pharmacokinetic/Pharmacodynamic (PK/PD) Franchise leader for oncology she develops M&S strategies and provides guidance to peers and project teams to select the most favorable compounds and optimal dose and dosing regimen in cancer patients with translational M&S.
Dr. Johannes Mohr is assistant head of division 614, Development of Methods and Structures in the Life Sciences, at the Federal Ministry of Education and Research (BMBF) since 2016. Dr. Mohr studied physics and received his PhD from the Technical University of Berlin.
PD Dr. Karsten Rippe is spokesperson of the e:Med project committee and since April 2007 group leader of the Research Group Genome Organization & Function at the German Cancer Research Center (DKFZ) and the BioQuant in Heidelberg. He is head of the e:Med consortium for systems medicine CancerTelSys, identifying cancer telomere maintenance networks for diagnosis, prognosis, patient stratification and therapy response prediction.
Professor Dr. Blanche Schwappach is research dean of the University Medical Center Göttingen and head of the department of molecular biology. She received her PhD from the University Hamburg in 1996. After working as a scientist in San Franciso, Heidelberg and Manchester, she joined the University of Göttingen in 2010 where she became Professor and Director of the Department of Molecular Biology. Her research focus is membrane protein biogenesis in different physiological conditions.
Professor Dr. Tanja Zeller is spokesperson of the e:Med project committee and professor for Genomics and Systems Biology at the University Heart Center Hamburg. She is head of the e:Med junior research alliance symAtrial. In her research, she investigates the molecular mechanisms of atrial fibrillation and additional cardiovascular diseases with the aim to identify genes and signaling pathways contributing to disease.